1. Home
  2. KNSA vs PTEN Comparison

KNSA vs PTEN Comparison

Compare KNSA & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • PTEN
  • Stock Information
  • Founded
  • KNSA 2015
  • PTEN 1978
  • Country
  • KNSA United Kingdom
  • PTEN United States
  • Employees
  • KNSA N/A
  • PTEN N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • PTEN Oil & Gas Production
  • Sector
  • KNSA Health Care
  • PTEN Energy
  • Exchange
  • KNSA Nasdaq
  • PTEN Nasdaq
  • Market Cap
  • KNSA 2.1B
  • PTEN 2.3B
  • IPO Year
  • KNSA 2018
  • PTEN 1993
  • Fundamental
  • Price
  • KNSA $27.53
  • PTEN $5.94
  • Analyst Decision
  • KNSA Strong Buy
  • PTEN Buy
  • Analyst Count
  • KNSA 5
  • PTEN 13
  • Target Price
  • KNSA $38.80
  • PTEN $9.85
  • AVG Volume (30 Days)
  • KNSA 1.1M
  • PTEN 13.1M
  • Earning Date
  • KNSA 07-22-2025
  • PTEN 07-23-2025
  • Dividend Yield
  • KNSA N/A
  • PTEN 5.39%
  • EPS Growth
  • KNSA N/A
  • PTEN N/A
  • EPS
  • KNSA N/A
  • PTEN N/A
  • Revenue
  • KNSA $481,166,000.00
  • PTEN $5,148,088,000.00
  • Revenue This Year
  • KNSA $37.21
  • PTEN N/A
  • Revenue Next Year
  • KNSA $5.32
  • PTEN N/A
  • P/E Ratio
  • KNSA N/A
  • PTEN N/A
  • Revenue Growth
  • KNSA 59.45
  • PTEN 5.82
  • 52 Week Low
  • KNSA $17.38
  • PTEN $5.12
  • 52 Week High
  • KNSA $30.69
  • PTEN $11.27
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 54.29
  • PTEN 45.56
  • Support Level
  • KNSA $27.62
  • PTEN $5.67
  • Resistance Level
  • KNSA $29.23
  • PTEN $6.69
  • Average True Range (ATR)
  • KNSA 1.03
  • PTEN 0.28
  • MACD
  • KNSA -0.21
  • PTEN -0.03
  • Stochastic Oscillator
  • KNSA 46.99
  • PTEN 21.23

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About PTEN Patterson-UTI Energy Inc.

Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.

Share on Social Networks: